Paul Brons

657 total citations
10 papers, 253 citations indexed

About

Paul Brons is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Paul Brons has authored 10 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Genetics and 2 papers in Surgery. Recurrent topics in Paul Brons's work include Blood Coagulation and Thrombosis Mechanisms (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Hemophilia Treatment and Research (2 papers). Paul Brons is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Hemophilia Treatment and Research (2 papers). Paul Brons collaborates with scholars based in Netherlands, Germany and France. Paul Brons's co-authors include Waander L. van Heerde, Bert Verbruggen, Frank R. van Genderen, Maria W. G. Nijhuis–van der Sanden, Marian van Kraaij, Arnoud Loof, J.B.M. Boezeman, Britta A. P. Laros‐van Gorkom, Mark van Geffen and Martha A. Grootenhuis and has published in prestigious journals such as PEDIATRICS, British Journal of Haematology and American Journal of Hematology.

In The Last Decade

Paul Brons

10 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Brons Netherlands 9 184 49 33 32 26 10 253
Jayson Stoffman Canada 8 127 0.7× 18 0.4× 34 1.0× 61 1.9× 17 0.7× 15 261
Faris Madanat Jordan 9 87 0.5× 22 0.4× 52 1.6× 9 0.3× 8 0.3× 18 215
D. W. Gorst United Kingdom 9 147 0.8× 28 0.6× 75 2.3× 19 0.6× 8 0.3× 27 307
Sanna‐Maria Kivivuori Finland 11 25 0.1× 53 1.1× 48 1.5× 43 1.3× 23 0.9× 21 262
Marios Kouloumas United Kingdom 6 85 0.5× 22 0.4× 7 0.2× 23 0.7× 5 0.2× 8 311
Inmaculada Soto Spain 9 187 1.0× 33 0.7× 22 0.7× 12 0.4× 46 1.8× 28 257
Letícia Gonçalves Freitas Brazil 10 75 0.4× 38 0.8× 139 4.2× 14 0.4× 29 1.1× 14 371
Jordi Bellart Spain 11 139 0.8× 16 0.3× 136 4.1× 38 1.2× 32 1.2× 23 341
Lynn Malec United States 10 248 1.3× 45 0.9× 10 0.3× 26 0.8× 29 1.1× 43 294
Sarah Wall United States 9 98 0.5× 31 0.6× 21 0.6× 12 0.4× 4 0.2× 54 250

Countries citing papers authored by Paul Brons

Since Specialization
Citations

This map shows the geographic impact of Paul Brons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Brons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Brons more than expected).

Fields of papers citing papers by Paul Brons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Brons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Brons. The network helps show where Paul Brons may publish in the future.

Co-authorship network of co-authors of Paul Brons

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Brons. A scholar is included among the top collaborators of Paul Brons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Brons. Paul Brons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Millot, Frédéric, et al.. (2019). Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study. British Journal of Haematology. 185(4). 718–724. 27 indexed citations
2.
Sanders, Yvonne, Karin Fijnvandraat, Johan Boender, et al.. (2015). Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric‐specific bleeding. American Journal of Hematology. 90(12). 1142–1148. 44 indexed citations
3.
Minford, Adrian, Wolfgang Behnisch, Paul Brons, et al.. (2014). Subcutaneous protein C concentrate in the management of severe protein C deficiency – experience from 12 centres. British Journal of Haematology. 164(3). 414–421. 20 indexed citations
4.
Westra, Dineke, Eiske M. Dorresteijn, Auke Beishuizen, et al.. (2012). The challenge of managing hemophilia A and STEC-induced hemolytic uremic syndrome. Pediatric Nephrology. 28(2). 349–352. 1 indexed citations
5.
Engelen, Vivian, Hendrik M. Koopman, Symone Detmar, et al.. (2012). The influence of patient reported outcomes on the discussion of psychosocial issues in children with cancer. Pediatric Blood & Cancer. 59(1). 161–166. 33 indexed citations
6.
Vrancken, Sabine L., et al.. (2011). Long-term Subcutaneous Protein C Replacement in Neonatal Severe Protein C Deficiency. PEDIATRICS. 127(5). e1338–e1342. 26 indexed citations
7.
Geffen, Mark van, Arnoud Loof, J.B.M. Boezeman, et al.. (2011). A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis. Hematology. 16(6). 327–336. 51 indexed citations
8.
Genderen, Frank R. van, et al.. (2009). Participation and risk‐taking behaviour in sports in children with haemophilia. Haemophilia. 15(3). 686–694. 24 indexed citations
9.
Weemaes, Corry M.R., Frank Preijers, Paul Brons, et al.. (2006). B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells.. PubMed. 91(12). 1705–9. 14 indexed citations
10.
Boekhorst, J. C. A., Bert Verbruggen, Jean‐Marc Costa, et al.. (2005). Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population. British Journal of Haematology. 131(1). 109–117. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026